Diplomat Announces 3rd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Diplomat Pharmacy (DPLO) Tops Q3 EPS by 10c; Lifts FY15 Outlook
November 3, 2015 4:20 PM ESTDiplomat Pharmacy (NYSE: DPLO) reported Q3 EPS of $0.26, $0.10 better than the analyst estimate of $0.16. Revenue for the quarter came in at $947 million versus the consensus estimate of $926.41 million.
Diplomat Pharmacy sees FY2015 EPS of $0.69-$0.73, versus prior guidance of $0.56-$0.60 and the consensus of... More



